Episode 6: Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma Episode 6: Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma

Drs Peter Martin and Anita Kumar discuss covalent and noncovalent Bruton tyrosine kinase (BTK) inhibitors in the frontline setting, BTK mutations, and the complicated mechanisms of resistance.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news